1. | redoctober30 | |
2. | hawktalkin | |
3. | chulwus | |
4. | danvettraino49 | |
5. | fpoapril |
1. | redoctober30 | |
2. | hawktalkin | |
3. | chulwus | |
4. | danvettraino49 | |
5. | fpoapril |
1. | chulwus 04/30/2018 AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting |
2. | hawktalkin 02/14/2018 Announced that the FDA |
3. | hawktalkin 02/13/2018 Reports Q4 earnings of $0.07 per share. |
4. | redoctober30 02/13/2018 ER |
5. | redoctober30 01/08/2018 Most recent news: - Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones |
6. | redoctober30 04/25/2018 Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions |